Healthcare Industry News: vascular access
News Release - August 18, 2009
Hemostatic HemCon(R) Dressings selected by the Premier healthcare alliance for Hemostasis Products ContractPORTLAND, Ore., Aug 18--(HSMN NewsFeed)--HemCon Medical Technologies, Inc. today announced that the hemostatic HemCon Patch(TM) and HemCon(R) Bandage were the only two products added to the Hemostasis Products category with Premier Purchasing Partners L.P., the group purchasing unit of Premier Inc. The contract is effective August 1, 2009 through Oct 1, 2011. The agreement makes HemCon dressings available at pre-negotiated terms to all 2,100 Premier hospital members through HemCon’s exclusive distribution partner, Cardinal Health.
Through this new contract, Premier members will now have access to special pricing for HemCon dressings, which are intended to improve patient care following diagnostic and interventional vascular access procedures. The dressings offer safe and fast hemostasis with an effective antibacterial barrier against a wide spectrum of microorganisms including MRSA, VRE and Acinetobacter baumannii that may help to reduce the risk of hospital acquired infections.
“HemCon is pleased to be included as a contracted supplier for Premier. Our company is committed to creating new healthcare products that drive improved patient safety and better, clinical results. We’re excited that Premier will make our revolutionary hemostatic products available to their members,” said HemCon Chief Executive Officer John W. Morgan.
The hemostatic HemCon Patch, designed for vascular closure following diagnostic and interventional cardiac catheterization procedures, was highlighted as the only such device to be selected for the Premier’s inaugural Innovation Celebration. The event celebrated advances in healthcare and highlighted industry leaders committed to innovation and improving care.
About Premier Inc., 2006 Malcolm Baldrige National Quality Award recipient
The Premier healthcare alliancePremier healthcare alliance is more than 2,100 U.S. hospitals and 58,000-plus other healthcare sites working together to improve healthcare quality and affordability. Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier works with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Premier has offices in San Diego, Charlotte, N.C., Philadelphia and Washington.
About HemCon Medical Technologies, Inc.
HemCon Medical Technologies, Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances including lyophilized human plasma and nanofiber technologies for wound care. HemCon is headquartered in Portland, Ore., with additional commercial operations in Ireland, England, Germany and the Czech Republic. For more information, please visit www.hemcon.comwww.hemcon.com.
Source: HemCon Medical Technologies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.